跳至主要内容
临床试验/IRCT20221202056684N1
IRCT20221202056684N1已完成3 期

The effect of ultrasound guided intramuscular injection of botulinum toxin (type A) in the distal of the vastus lateralis muscle on pain relief and performance improvement in patients with patellofemoral pain syndrome: A randomized clinical trial

Shahid Beheshti University of Medical Sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 45 years(—)
性别
All

入选标准

  • Patients aged 18 to 45 years
  • Clinical diagnosis of PFP syndrome for more than 3 months
  • Pain rating (out of 10) 4 or more
  • Failure to respond to treatment despite receiving at least 8 weeks of non-invasive treatment including exercise therapy, exercise therapy and physical therapy

排除标准

  • Presence of knee joint effusion
  • Presence of any evidence in favor of other tibiofemoral pathologies (patellar tendinopathy, presence of evidence of tibiofemoral osteoarthritis or patellofemoral joint space narrowing or arthrosis on radiographs (Kellgren-Lawrence grade II or higher), meniscal tear, knee instability)
  • Evidence in favor of spinal canal stenosis, lumbar radiculopathy, neuropathy and lower limb neuronal damage
  • Any intra-articular injection of the knee in the last 6 months (including hyaluronic acid, ozone or steroids)
  • Body mass index > 35
  • Previous knee surgery
  • Evidence of injury or inflammatory arthritis of the hip joint
  • Allergy to BoNT-A

研究者

相似试验